NANOBIOTIX to Participate in Investor Conferences the Week of November 10th

Core Insights - Nanobiotix, a late-stage clinical biotechnology company, is focused on pioneering nanotherapeutic approaches to enhance treatment options for cancer and other significant diseases [1][3][4]. Conference Participation - The company management will participate in several upcoming conferences, including: - UBS Global Healthcare Conference on November 10, 2025, at 5pm ET in Palm Beach Gardens, FL, presented by Bart van Rhijn, Chief Financial & Business Officer [1]. - Guggenheim's Annual Healthcare Innovation Conference on November 10, 2025, at 4:30pm ET in Boston, MA, presented by Laurent Levy, Chief Executive Officer [2]. - Stifel Healthcare Conference on November 13, 2025, at 8am ET in New York, NY, presented by Laurent Levy and Bart van Rhijn [2]. Company Overview - Nanobiotix, incorporated in 2003 and headquartered in Paris, France, is listed on Euronext Paris since 2012 and on Nasdaq since December 2020 [4]. - The company holds over 25 patent families related to three nanotechnology platforms, focusing on oncology, bioavailability and biodistribution, and central nervous system disorders [4].